Ticker brief
CVS CVS HEALTH CORP
Consumer, Non-cyclical · Pharmaceuticals
last close
$93.47
1 day
-1.1%
14 days
+8.5%
mkt cap
$133.6B
signals 14d
36
authors 14d
31
crowd 14d
-2.2σ
Options inteloptions-surface reads · latest available day per source
| metric | reading | context |
|---|---|---|
| IV — ATM 30d | 36% mid · 79 pctile own 1y | IV/HV 1.42× |
| Skew — 25Δ RR 30d | +0.001 92 pctile own 1y | calls bid vs puts (call skew rich) |
| Net dealer OI (NDOI) | +0.87 normal | 5-session Δ -0.09 (as of 2026-07-06) |
| OI alarm | quiet | last alarm 2025-01-07 (z=2.9) |
| Next earnings | 2026-11-04 (proj) | in 9d |
| CSP screen | rank #142 · $90.0 strike · 0.31% prem | on the CSP screen (2026-10-23) |
Sentiment — last 14 days
daily mean sentiment, 2026-10-03 → 2026-10-16 · now +0.05 (−1 bearish … +1 bullish)
Who spoke31
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @OptionSamurai | C | · | 3 | +0.42 |
| @AccesswireNews | C | · | 2 | +0.13 |
| @Capitol_Forum | A | -0.51 | 2 | -0.08 |
| @WSJ | A | -0.25 | 2 | -0.30 |
| @Trading_Sunset | C | -2.68 | 1 | -0.70 |
| @PeloSwing | C | +1.05 | 1 | +0.00 |
| @Benzinga | C | +0.17 | 1 | -0.25 |
| @42traders | B | -1.22 | 1 | +0.20 |
| @ManOnThePen | B | +0.61 | 1 | +0.10 |
| @Fiscal_ai | B | -1.43 | 1 | -0.10 |
| @tenet_research | C | -1.23 | 1 | +0.05 |
| @AlexsOptions | C | -1.18 | 1 | +0.35 |
| @Financhle | C | · | 1 | +0.60 |
| @kiantrades | C | -1.01 | 1 | +0.45 |
| @Globalmess65 | C | +1.68 | 1 | +0.00 |
| @ElliottWaveSage | C | +0.28 | 1 | +0.15 |
| @TradeCycles | C | -1.74 | 1 | -0.50 |
| @twinsight_x | C | +2.87 | 1 | -0.10 |
| @scottmelker | C | +1.93 | 1 | -0.30 |
| @OracleNYSE | C | +0.83 | 1 | -0.20 |
| @faststocknewss | C | +1.70 | 1 | -0.20 |
| @MktBrain_US | C | +0.35 | 1 | -0.20 |
| @CrweWorld | C | · | 1 | -0.30 |
| @BarbarianCap | B | +1.97 | 1 | -0.20 |
| @bioinvestor24 | A | -0.87 | 1 | -0.80 |
Recent signals30of 36 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-10-16 | @Capitol_Forum | +0.00 | Reports a proposal to end IDR arbitration and growing pressure to overhaul the No Surprises Act. | +1.2% | tweet ↗ |
| 2026-10-16 | @AccesswireNews | +0.10 | CVS Caremark promotes changes intended to transform the health-care experience. | +1.2% | tweet ↗ |
| 2026-10-15 | @USAnt_IDEA | -0.55 | Argues Medicare Advantage economics are deteriorating and insurers face lasting pressure. | +1.0% | tweet ↗ |
| 2026-10-15 | @TrendSpider | +0.55 | Suggests CVS has broken or ended its prior downtrend. | +1.0% | tweet ↗ |
| 2026-10-15 | @OwenGregorian | -0.25 | CVS agreed to a $315 million DOJ settlement resolving opioid-dispensing allegations. | +1.0% | tweet ↗ |
| 2026-10-14 | @MrTrendwatch | +0.70 | Buy CVS on a 3-of-4 KeKoa signal. — Issues an explicit buy signal for CVS. | +3.4% | tweet ↗ |
| 2026-10-14 | @zerohedge | +0.12 | CVS will pay $315M to resolve claims involving unlawful opioid prescriptions. | +3.4% | tweet ↗ |
| 2026-10-14 | @OptionSamurai | +0.40 | Scan presents a CVS covered-call dividend-capture setup with quantified return and breakeven. | +3.4% | tweet ↗ |
| 2026-10-14 | @CHItrader | +0.20 | CVS agreed to a $315M settlement over alleged illegal opioid prescriptions. | +3.4% | tweet ↗ |
| 2026-10-13 | @bioinvestor24 | -0.80 | Calls CVS a rip-off based on poor consumer pricing with or without insurance. | +6.8% | tweet ↗ |
| 2026-10-13 | @BarbarianCap | -0.20 | A CVS unit will pay $315 million to resolve illegal opioid-prescription claims. | +6.8% | tweet ↗ |
| 2026-10-13 | @CrweWorld | -0.30 | CVS agreed to pay $315 million over unlawful opioid prescriptions and false claims. | +6.8% | tweet ↗ |
| 2026-10-13 | @WSJ | -0.30 | CVS agreed to pay $315 million to resolve opioid-prescription and Medicare false-claims allegations. | +6.8% | tweet ↗ |
| 2026-10-13 | @WSJ | -0.30 | The U.S. alleges CVS knowingly filled invalid controlled-substance prescriptions. | +6.8% | tweet ↗ |
| 2026-10-13 | @MktBrain_US | -0.20 | CVS agreed to pay $315 million to settle opioid-dispensing and false-claims allegations. | +6.8% | tweet ↗ |
| 2026-10-13 | @faststocknewss | -0.20 | CVS agreed to pay $315M over unlawful opioid prescriptions and false federal claims. | +6.8% | tweet ↗ |
| 2026-10-13 | @OracleNYSE | -0.20 | CVS agreed to pay $315M to resolve opioid-prescription and false-claims allegations. | +6.8% | tweet ↗ |
| 2026-10-09 | @scottmelker | -0.30 | Reports favorable HUM ratings, Delta's guidance cut, and weaker projected star ratings for UNH and CVS. | +8.5% | tweet ↗ |
| 2026-10-09 | @twinsight_x | -0.10 | Compares divergent intraday performance among managed-care stocks. | +8.5% | tweet ↗ |
| 2026-10-09 | @TradeCycles | -0.50 | Reports opposing CMS star-rating actions and resulting price moves for HUM and CVS. | +8.5% | tweet ↗ |
| 2026-10-09 | @ElliottWaveSage | +0.15 | Humana reported a sharp increase in members enrolled in 4-star-plus Medicare Advantage plans. | +8.5% | tweet ↗ |
| 2026-10-09 | @Globalmess65 | +0.00 | Questions the consumer relevance of Medicare star ratings and notes HUM may not have raised guidance. | +8.5% | tweet ↗ |
| 2026-10-08 | @Capitol_Forum | -0.15 | Antimonopoly groups seek future corporate probes and antitrust legislation. | +6.5% | tweet ↗ |
| 2026-10-08 | @AccesswireNews | +0.15 | Aetna announced its 2027 Medicare plan offering. | +6.5% | tweet ↗ |
| 2026-10-07 | @kiantrades | +0.45 | Lists notable bullish call flow and bearish put flow with strikes, expiries and premiums. | +6.3% | tweet ↗ |
| 2026-10-07 | @OptionSamurai | +0.45 | Use a CVS 89 covered call expiring 2026-10-30 for dividend capture. — Presents a concrete forward covered-call setup with return and breakeven metrics. | +6.3% | tweet ↗ |
| 2026-10-07 | @Financhle | +0.60 | Reports a $210.5K aggressive purchase of two-day CVS $90 calls amid bullish flow. | +6.3% | tweet ↗ |
| 2026-10-07 | @OptionSamurai | +0.40 | Use the CVS 84 put expiring 2026-11-06 as a wheel-strategy entry. — Concrete forward cash-secured-put and wheel setup with quantified returns. | +6.3% | tweet ↗ |
| 2026-10-07 | @AlexsOptions | +0.35 | Buy names taking yesterday's highs; XLV received a buy signal this morning. — Author gives a breakout-buy condition and says algorithms switched to buying healthcare. | +6.3% | tweet ↗ |
| 2026-10-07 | @tenet_research | +0.05 | CVS reminded New Yorkers that MMR vaccines are available statewide during the outbreak. | +6.3% | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.